Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/15/2024 | BVF INC/IL | 443,221 | $1.72 M | 0.00% | 1.35% |
05/15/2024 | SUVRETTA CAPITAL MANAGEMENT, LLC | 400,000 | $1.68 M | 0.00% | 1.22% |
05/15/2024 | TANG CAPITAL MANAGEMENT LLC | 100,000 | $420,000 | 0.00% | 0.31% |
05/15/2024 | ROYAL BANK OF CANADA | 1,500 | $6,000 | 100.00% | 0.00% |
05/15/2024 | MORGAN STANLEY | 367 | $1,424 | 0.00% | 0.00% |
05/13/2024 | UBS GROUP AG | 326 | $1,265 | 100.00% | 0.00% |
05/09/2024 | RHUMBLINE ADVISERS | 269 | $1,043 | 0.00% | 0.00% |
05/14/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 16 | $62 | 0.00% | 0.00% |
05/10/2024 | JPMORGAN CHASE & CO | 0 | $0 | -100.00% | 0.00% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 12 institutional investors and hedge funds held shares of Molecular Partners AG. The most heavily invested institutionals were:
BVF INC/IL: 443,221
SUVRETTA CAPITAL MANAGEMENT, LLC: 400,000
TANG CAPITAL MANAGEMENT LLC: 100,000
ROYAL BANK OF CANADA: 1,500
MORGAN STANLEY: 367
UBS Group AG: 326
A. 2.89% of Molecular Partners AG stock is owned by institutional investors.
A. Institutional investors have bought a total of 945,700 shares in the last 24 months. This purchase volume represents approximately $6.26 M in transactions.